Related Experiment Video
Updated: May 28, 2025

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
A potential tumor suppressor role of PLK2 in glioblastoma
Xiangping Xia1,2, Peirui Wang2, Hua Xiao2
1Soochow University Medical College, Suzhou, China.
Abstract:
Glioblastoma (GBM) is a highly malignant brain tumor with limited treatment options. Polo-like kinase 2 (PLK2), a member of the polo-like kinase family, has been variably implicated in cancer, but its role in GBM has not been fully elucidated. We utilized RNA-seq data from multiple databases, including Gene Expression Omnibus (GEO), the Cancer Genome Atlas (TCGA), and the Chinese Glioma Genome Atlas (CGGA), and conducted experiments on human glioma cell lines to explore PLK2's expression and function. The effects of PLK2 overexpression on GBM cell viability, proliferation, migration, cell cycle, and apoptosis were assessed, and the tumorigenic potential of PLK2 was evaluated in a mouse model. PLK2 was consistently downregulated in GBM tissues compared to normal brain tissues across several datasets. Overexpression of PLK2 in GBM cell lines U87MG and U251 reduced their tumorigenic potential and enhanced cell cycle arrest and apoptosis, with significant reductions observed in apoptosis markers. Our findings suggest that PLK2 may potentially function as a tumor suppressor in GBM. Hence, PLK2 overexpression could potentially be leveraged as a therapeutic strategy to inhibit tumor progression and enhance apoptosis, providing new avenues for GBM treatment.
Insights
Polo-like kinase 2 (PLK2) is downregulated in glioblastoma (GBM). Overexpressing PLK2 suppressed GBM tumor growth, offering a potential new therapeutic strategy for this aggressive brain cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
- The role of Polo-like kinase 2 (PLK2) in GBM pathogenesis is not well understood.
- Limited therapeutic options exist for GBM patients.
Purpose of the Study:
- To investigate the expression and function of PLK2 in glioblastoma.
- To determine the potential of PLK2 as a therapeutic target for GBM.
Main Methods:
- Analysis of RNA-seq data from GEO, TCGA, and CGGA databases.
- Experiments on human U87MG and U251 GBM cell lines.
- In vivo evaluation of PLK2's tumorigenic potential in a mouse model.
Main Results:
- PLK2 expression was consistently downregulated in GBM tissues compared to normal brain.
- Overexpression of PLK2 in GBM cells reduced viability, proliferation, and migration.
- PLK2 overexpression induced cell cycle arrest and enhanced apoptosis in GBM cells.
Conclusions:
- PLK2 acts as a tumor suppressor in glioblastoma.
- Therapeutic strategies involving PLK2 overexpression may inhibit GBM progression.
- PLK2 represents a potential novel therapeutic target for glioblastoma treatment.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity
Negative Regulator Molecules